You are here: Industry Insights > cancer immunotherapy

News List

NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer firstwordpharma
June 16, 2021
NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, and PICI announced today that they are collaborating on an expansive molecular characterization project for cellular therapies.
BioInvent Signs Manufacturing Agreement contractpharma
May 05, 2020
Includes process development and conjugation of two antibodies in BioInvent's labs.
Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy b3cnewswire
March 23, 2020
Vaccitech Limited and the University of Oxford today announce initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC).
Cancer immunotherapy market to hit $115bn by 2023, says report europeanpharmaceuticalreview
January 09, 2020
New research analysis has predicted that immunotherapy will become the oncology treatment of choice, with the market reaching $115 billion by 2023.
AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial americanpharmaceuticalreview
January 17, 2019
AIVITA Biomedical announced the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1B clinical trial investigating the Company's ROOT OF CANCER technology in .....
Innovent Announces First Patient Dosed in Anti-CD47 Trial americanpharmaceuticalreview
January 16, 2019
Innovent Biologics announced the first patient has been successfully dosed in a phase I clinical trial of anti-CD47 monoclonal antibody (IBI188) for patients with advanced malignancies....
Sanofi invests €80M in BioNTech as cancer mRNA hits clinic fiercebiotech
January 07, 2019
Sanofi is set to invest €80 million ($91 million) in BioNTech and extend its cancer collaboration with the German mRNA specialist. The agreement comes as BioNTech and Sanofi prepare to .....
Boosting cancer immunotherapy by switching off a protein fiercebiotech
August 06, 2018
Regulatory T cells, or Tregs, ensure our immune responses don’t spin out of control and can cause autoimmune diseases. But on the flip side, they can also limit the power of the immune system to fight cancer.
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology prnasia
September 26, 2017
EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and immune-engineering today announced the launch of EpiVax Oncology Inc.
Research by NCI determines necessary genes for cancer immunotherapy cphi-online
August 09, 2017
The research could accelarate the advancement of a new category of drugs.

Previous page 1 2 Next page